Comparison of a fixed dose of 0.15% Hypobaric and 0.5% Hyperbaric Bupivacaine for short- term unilateral lower limb orthopedic surgeries. Retrospective study with two videos
Comparison of a fixed dose of 0.15% Hypobaric and 0.5% Hyperbaric Bupivacaine for short- term unilateral lower limb orthopedic surgeries. Retrospective study with two videos
MedCrave Group LLC is a participating organization of the ORCiD
proposal and
authors are necessary to present their ORCiD figures at submission whenever available.
ORCiD?
ORCiD is the source of a determined digital identifier that is unique to you. This
differentiates you
from every other researcher, which is important when others encompass the identical or similar names.
Incorporation in manuscript and grant submission it supports robotic relationship between you and your
professional actions guarantee that your work is familiar, and you acquire credit wherever it is outstanding.
Getting an ORCiD id is easy, quick and free to do through the ORCiD registration page:
What are the advantages to authors having an ORCiD iD?
Frequently lots of researchers having similar name, even there is also researchers who possibly
will transform their name or publish with dissimilar names in their career. By having ORCiD iD, people will be
properly associated with their research work only. Also if you use your ORCiD iD during
initial submission
process and grant Crossref permission, we will update your ORCiD evidence whenever you
publish an article with us.
Crossref will send a notification to your ORCiD inbox requesting permission to update
your your ORCiD evidence whenever you publish an article with us.
Crossref will send a notification to your ORCiD inbox requesting permission to update
your ORCiD record with your published article. Please see: